Try Alerts Free   |   Login
Health Care › Dental Equipment And Supplies

NVST Price Correlated With Financials For Envista Holdings

Free historical financial statements for Envista Holdings Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 11 quarters since 2020. Compare with NVST stock chart to see long term trends.

NVST Stock Compared to Quarterly

NVST Income Statement

Revenue, Net:631100000
Revenue Per Share:3.8694
Cost of Goods & Services Sold:266400000
Gross Profit:364700000
Selling, General & Admin Expense:264200000
Research & Development Expense:26000000
Operating Income:74500000
Income Taxes:13600000
Net Income:47600000
Earnings Per Share, Basic:0.3
Shares Outstanding, Basic Avg:163100000

NVST Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:19900000
Net Cash from Operations:46700000
Net Cash from Operations Per Share:0.2863
Net Cash from Financing Activities:73700000
Property, Plant & Equipment Purchases:26900000
Purchases of Businesses, Net of Cash:null
Net Cash from Investing Activities:-69700000
Net Change in Cash & Equivalents:45400000

NVST Balance Sheet

Cash and Cash Equivalents:568500000
Accounts Receivable, Net:392200000
Inventories:291300000
Total Current Assets:1366000000
Property, Plant & Equipment, Net:277200000
Total Assets:6411900000
Total Short-Term Liabilities:1258300000
Long Term Debt, Non-Current Portion:851600000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
17,809,610 sh
-262,184 sh
-1%
$584,333
-$112,154
Vanguard Group Inc
15,702,756 sh
270,768 sh
2%
$515,208
-$79,541
FMR LLC
12,077,175 sh
-4,213,821 sh
-26%
$396,251
-$231,604
Massachusetts Financial Services Co /Ma/
11,124,106 sh
651,953 sh
6%
$364,983
-$38,615
Atlanta Capital Management Co L L C
10,472,529 sh
203,155 sh
2%
$343,604
-$52,178
Lazard Asset Management LLC
6,959,609 sh
2,895,238 sh
71%
$228,344
$71,704
Boston Partners
6,341,406 sh
1,969,963 sh
45%
$208,262
$39,098
Artisan Partners Limited Partnership
5,861,039 sh
623,479 sh
12%
$192,301
-$9,555
Ariel Investments, LLC
5,299,570 sh
-155,839 sh
-3%
$173,879
-$36,372
Dimensional Fund Advisors LP
4,876,360 sh
611,169 sh
14%
$159,997
-$4,383
State Street Corp
4,544,129 sh
145,786 sh
3%
$149,093
-$20,419
Citadel Advisors LLC
3,956,083 sh
3,936,883 sh
20505%
$129,799
$129,059
Macquarie Group Ltd
3,478,574 sh
-280,921 sh
-7%
$114,208
-$30,683
Montrusco Bolton Investments Inc.
3,352,257 sh
694,581 sh
26%
$108,630
$7,426
Millennium Management LLC
2,967,043 sh
437,734 sh
17%
$97,349
-$131
Alliancebernstein L.P.
2,796,552 sh
22,845 sh
1%
$91,755
-$15,144
JPMorgan Chase & Co
2,786,387 sh
-219,095 sh
-7%
$91,421
-$24,411
Franklin Resources Inc
2,551,408 sh
3,155 sh
0%
$83,712
-$14,497
Geode Capital Management, LLC
2,497,172 sh
49,820 sh
2%
$81,932
-$12,388
Jennison Associates LLC
2,468,787 sh
139,657 sh
6%
$81,001
-$8,764
COMPANY PROFILE
BUSINESS AND BASIS OF PRESENTATION Separation and Initial Public Offering

Envista Holdings Corporation (together with its subsidiaries, “Envista” or the “Company”) was formed as a wholly-owned subsidiary of Danaher Corporation (“Danaher”). Danaher formed Envista to ultimately acquire, own and operate the Dental business of Danaher. On September 20, 2019, the Company completed an initial public offering (“IPO”) resulting in the issuance of 30.8 million shares of its common stock (including shares issued pursuant to the underwriters’ option to purchase additional shares) to the public, which represented 19.4% of the Company’s outstanding common stock, at $22.00 per share, the initial public offering price, for total net proceeds, after deducting underwriting discounts and commissions, of $643.4 million. In connection with the completion of the IPO, through a series of equity and other transactions, Danaher transferred substantially all of its Dental business to the Company. As consideration for the transfer of the Dental business to the Company, the Company paid Danaher approximately $2.0 billion, which included the net proceeds from the IPO and the net proceeds from term debt financing, as further discussed in Note 16, and issued to Danaher 127.9 million shares of the Company’s common stock. The transactions described above related to the transfer of the Dental business are collectively referred to herein as the “Separation.”

On November 15, 2019, Danaher announced an exchange offer whereby Danaher stockholders could exchange all or a portion of Danaher common stock for shares of the Company’s common stock owned by Danaher. The disposition of the Company’s shares was completed on December 18, 2019 and resulted in the full separation of the Company and disposal of Danaher’s entire ownership and voting interest in the Company.

Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.

The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation

For periods after the Separation, the financial statements are prepared on a consolidated basis. Prior to the Separation, the Company operated as part of Danaher and not as a separate, publicly-traded company and the Company’s financial statements are combined, have been prepared on a stand-alone basis and are derived from Danaher's consolidated financial statements and accounting records. The Consolidated and Combined Financial Statements reflect the financial position, results of operations and cash flows related to the Dental business that was transferred to the Company. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included as a component in the financial statements. Prior to the Separation, the financial statements also included allocations of ce

Data imported from Envista Holdings Corp SEC filings. Check original filings before making any investment decision.